Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Tutt

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
The EMBO Journal|September 5, 2001
Mutation in Brca2 stimulates error-prone homology-directed repair of DNA double-strand breaks occurring between repeated sequencesA Tutt, D Bertwistle, J Valentine, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1995
Engineered anti-CD38 monoclonal antibodies for immunotherapy of multiple myelomaJ H Ellis, K A Barber, A Tutt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 21, 2019
A decade of clinical development of PARP inhibitors in perspectiveJ Mateo, C J Lord, V Serra, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 3, 2021
Adjuvant Breast Radiotherapy at an Academic Centre during the COVID-19 Pandemic: Reassuringly SafeN Hanumanthappa, C Goldsmith, E Sawyer, et al.
Familial Cancer|March 20, 2010
Novel one-stop multidisciplinary follow-up clinic significantly improves cancer risk management in BRCA1/2 carriersG Pichert, C Jacobs, I Jacobs, et al.
Pediatrics|October 3, 2007
Effects of nurse home visiting on maternal and child functioning: age-9 follow-up of a randomized trialDavid L Olds, Harriet Kitzman, Carole Hanks, et al.
British Journal of Cancer|February 16, 2012
BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 yearsL Robertson, H Hanson, S Seal, et al.
Breast Cancer Research and Treatment|February 13, 2014
Assessment of microtubule-associated protein (MAP)-Tau expression as a predictive and prognostic marker in TACT; a trial assessing substitution of sequential docetaxel for FEC as adjuvant chemotherapy for early breast cancerS Irshad, C Gillett, S E Pinder, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 25, 2020
Assessment of structural chromosomal instability phenotypes as biomarkers of carboplatin response in triple negative breast cancer: the TNT trialO Sipos, H Tovey, J Quist, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 15, 2023
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upS Loibl, F André, T Bachelot, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
The EMBO Journal|September 5, 2001
Mutation in Brca2 stimulates error-prone homology-directed repair of DNA double-strand breaks occurring between repeated sequencesA Tutt, D Bertwistle, J Valentine, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1995
Engineered anti-CD38 monoclonal antibodies for immunotherapy of multiple myelomaJ H Ellis, K A Barber, A Tutt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 21, 2019
A decade of clinical development of PARP inhibitors in perspectiveJ Mateo, C J Lord, V Serra, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 3, 2021
Adjuvant Breast Radiotherapy at an Academic Centre during the COVID-19 Pandemic: Reassuringly SafeN Hanumanthappa, C Goldsmith, E Sawyer, et al.
Familial Cancer|March 20, 2010
Novel one-stop multidisciplinary follow-up clinic significantly improves cancer risk management in BRCA1/2 carriersG Pichert, C Jacobs, I Jacobs, et al.
Pediatrics|October 3, 2007
Effects of nurse home visiting on maternal and child functioning: age-9 follow-up of a randomized trialDavid L Olds, Harriet Kitzman, Carole Hanks, et al.
British Journal of Cancer|February 16, 2012
BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 yearsL Robertson, H Hanson, S Seal, et al.
Breast Cancer Research and Treatment|February 13, 2014
Assessment of microtubule-associated protein (MAP)-Tau expression as a predictive and prognostic marker in TACT; a trial assessing substitution of sequential docetaxel for FEC as adjuvant chemotherapy for early breast cancerS Irshad, C Gillett, S E Pinder, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 25, 2020
Assessment of structural chromosomal instability phenotypes as biomarkers of carboplatin response in triple negative breast cancer: the TNT trialO Sipos, H Tovey, J Quist, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 15, 2023
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upS Loibl, F André, T Bachelot, et al.
Pageof 3